ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1689

Addressing Perceived Discrimination in Lupus Care: Enhancing Patient Empowerment and Health Equity Through Education and Support

Kimberly Cabrera1, Priscilla Calvache2, Lillian Mendez3, Giselle Morales4 and Jillian Rose-Smith2, 1Hospital for Special Surgery, New York, 2Hospital for Special Surgery, New York, NY, 3Patient Advocate, Carteret, NJ, 4Hospital for Special Surgery, Glendale, NY

Meeting: ACR Convergence 2025

Keywords: Access to care, Disparities, education, patient, Patient reported outcomes, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: Abstracts: ARP I: Multidimensional Influences on Health in SLE (1686–1691)

Session Type: Abstract Session

Session Time: 3:45PM-4:00PM

Background/Purpose: SLE is a life-threatening autoimmune disease that disproportionately affects African American (AA), Hispanic/Latino, & Asian populations. These communities experience serious health disparities, including more severe illness & poorer health outcomes. Research highlights that perceived racial discrimination in healthcare is a major concern among SLE patients, particularly among AA patients, contributes to lower trust in physicians, treatment adherence, & worsened health outcomes. A hospital-based support & education program conducted a survey to identify lupus patients’ self-reported experiences with perceived discrimination & healthcare navigation.

Methods: A pre/post-test survey, including validated scales such as the Everyday Discrimination Scale (EDS) was disseminated online to lupus patients participating in monthly support group sessions. The survey assessed key areas, including disease activity, experiences of discrimination, & patient-provider communication. A pre-test was administered at the beginning of the year, followed by 6 virtual support group meetings that provided education on recognizing & intervening when discrimination occurs in healthcare settings.

Results: A total of 37 participants completed the pre-test, and 23 completed the post-test (n=56). Most respondents (82%) identified as female. The racial breakdown included 44% Black/AA, 21% White, 57% identifying as Hispanic/Latino, 27% identifying as other races, and 8% Asian. There was a notable concentration of respondents aged 30–39 (35%). (See Figure 1)
Using the criteria that responses other than “Never” indicate a discriminatory experience, analysis of the EDS revealed a decrease (â) in reported discrimination experiences from pre-test to post-test. Participants who reported being treated with less courtesy â by 24.3%, while reports of being treated with less respect â by 11.6%. Perceived poorer service âby 10% and reports of feeling that a doctor or nurse acted superior â by 6.5%.
However, some areas saw slight increase (á): participants reporting that a doctor or nurse did not listen á by 5.9%, and those perceiving that a healthcare provider believed they were not smart á by 4.3%. (See figure 2)

Conclusion: Despite limitations, this study affirms that tailored education & peer support can meaningfully reduce perceived discrimination and strengthen patient empowerment in lupus. Participants reported greater awareness, improved communication with providers, & enhanced healthcare navigation skills. These findings highlight the benefit of incorporating equity-driven, patient-centered programs into clinical & community settings to build trust, promote self-advocacy, & advance health equity for individuals living with SLE.

Supporting image 1Figure 1

Supporting image 2Figure 2


Disclosures: K. Cabrera: None; P. Calvache: None; L. Mendez: None; G. Morales: None; J. Rose-Smith: None.

To cite this abstract in AMA style:

Cabrera K, Calvache P, Mendez L, Morales G, Rose-Smith J. Addressing Perceived Discrimination in Lupus Care: Enhancing Patient Empowerment and Health Equity Through Education and Support [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/addressing-perceived-discrimination-in-lupus-care-enhancing-patient-empowerment-and-health-equity-through-education-and-support/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/addressing-perceived-discrimination-in-lupus-care-enhancing-patient-empowerment-and-health-equity-through-education-and-support/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology